x
Filter:
Filters applied
- ABOS Web Based Longitudinal Assessment Program
- conventional synthetic disease-modifying antirheumatic drugsRemove conventional synthetic disease-modifying antirheumatic drugs filter
- 2018 - 2023Remove 2018 - 2023 filter

American Board of Orthopaedic Surgery (ABOS)
ABOS Web Based Longitudinal Assessment Program
2023 Knowledge Sources
Please publish your next paper open access in Journal of Hand Surgery Global Online (JHS GO).
1 Results
- Current Concepts
Perioperative Management of Immunosuppressive Medications for Rheumatoid Arthritis
Journal of Hand SurgeryVol. 47Issue 4p370–378Published online: February 17, 2022- Andrew M. Hresko
- Christopher J. Got
- Joseph A. Gil
Cited in Scopus: 4Operations in patients with rheumatoid arthritis are complicated by the fact that most drugs used in medical management have immunosuppressive mechanisms of action, including corticosteroids and conventional synthetic and biologic disease-modifying antirheumatic drugs. In deciding to continue or discontinue these medications perioperatively, surgeons must weigh the relative risk of infection from immunosuppression against the risk of rheumatoid arthritis symptom flares from reduced medical disease control.